{"gene":"CUX1","run_date":"2026-06-09T22:57:19","timeline":{"discoveries":[{"year":2004,"finding":"Cathepsin L, via isoforms devoid of a signal peptide that localize to the nucleus during G1-S transition, proteolytically processes CDP/Cux (CUX1) to generate the p110 isoform, thereby regulating cell cycle progression.","method":"Ectopic expression of cathepsin L, Cat L(-/-) knockout cells, immunofluorescence imaging, activity-based probes for nuclear cathepsin L localization, in situ processing assay","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (KO cells, ectopic expression, activity-based probes, immunofluorescence), replicated in both gain- and loss-of-function contexts","pmids":["15099520"],"is_preprint":false},{"year":2001,"finding":"CDP/Cux (CUX1) DNA binding activity is up-regulated at G1/S transition by two events: dephosphorylation by Cdc25A phosphatase and proteolytic processing to generate the p110 isoform with stable DNA binding.","method":"Cell cycle synchronization, Western blot, EMSA, in vitro DNA binding assays","journal":"Gene","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — biochemical characterization from multiple lines of investigation consolidated in a review but referencing primary cell-based assays; single lab summary","pmids":["11403998"],"is_preprint":false},{"year":2001,"finding":"Cyclin A-Cdk1 binds CDP/Cux (CUX1) via the Cut homeodomain and a downstream Cy motif, and phosphorylates serines 1237 and 1270, thereby inhibiting CDP/Cux DNA binding activity in G2 and preventing repression of the p21(WAF1) promoter.","method":"In vitro kinase/binding assays, site-directed mutagenesis (S1237A/S1270A), co-immunoprecipitation, cotransfection reporter assays, cell synchronization","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro phosphorylation with mutagenesis validation, co-IP, and reporter assays in one study; single lab with multiple orthogonal methods","pmids":["11584018"],"is_preprint":false},{"year":2003,"finding":"N-terminally truncated CDP/Cux isoforms (p110) act as transcriptional activators of the DNA polymerase alpha gene promoter in S phase, whereas full-length CDP/Cux does not; ChIP confirmed S-phase-specific promoter occupancy.","method":"Cotransfection reporter assays, retroviral expression, chromatin immunoprecipitation (ChIP), linker scanning analysis, in vitro DNA binding","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP plus reporter assays plus endogenous gene activation; multiple orthogonal methods, single lab","pmids":["12665598"],"is_preprint":false},{"year":2002,"finding":"The CDP/Cux p75 isoform, generated by transcription initiation within intron 20, contains only Cut repeat 3 and the homeodomain, binds DNA stably, represses the p21 promoter, and activates the DNA polymerase alpha promoter; aberrant expression in breast tumor cells promotes undifferentiated growth.","method":"Northern/Western blot characterization, reporter assays (repression/activation), stable cell line experiments (collagen tubulogenesis assay)","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — biochemical isoform characterization plus functional cell-based assays; single lab, multiple methods","pmids":["12438259"],"is_preprint":false},{"year":2006,"finding":"A 90 kDa CDP/Cux isoform (p90) is generated by cathepsin L-mediated proteolytic processing, with its N-terminus between amino acids 918 and 938; p90 and p110 display similar DNA-binding and transcriptional activities.","method":"Deletion mutant mapping, co-expression with catalytically active cathepsin L isoforms lacking signal peptide, Western blot","journal":"Biological chemistry","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — biochemical mapping with deletion mutants and cathepsin L co-expression; single lab, two complementary approaches","pmids":["16972798"],"is_preprint":false},{"year":2008,"finding":"CUX1 (p110 isoform) and E2F1 co-occupy the promoters of Ect2, MgcRacGAP, and MKLP1 upon S-phase entry and cooperatively activate their transcription; CHR elements mediate G1 repression, and CUX1/E2F1 binding drives peak G2/M expression to coordinate cytokinesis.","method":"Chromatin immunoprecipitation (ChIP), promoter-luciferase reporter assays, dominant-negative and activated transcription factor expression, siRNA knockdown, Western blot","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP plus reporter assays plus loss-of-function siRNA, multiple orthogonal methods in one study","pmids":["19015243"],"is_preprint":false},{"year":2014,"finding":"CUX1 functions as an ancillary factor in base excision repair by directly stimulating OGG1 enzymatic activity via its CUT domains, accelerating repair of 8-oxoG lesions; elevated CUX1 prevents RAS-induced senescence by reducing oxidative DNA damage.","method":"In vitro base excision repair assays with purified CUX1 and OGG1, single-cell gel electrophoresis (comet assay) in Cux1+/- MEFs and elevated-CUX1 cells, RAS-induced senescence assay, transgenic mouse model","journal":"PLoS biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution with purified proteins, haploinsufficiency comet assay, and mouse model; multiple orthogonal methods across genetic and biochemical approaches","pmids":["24618719"],"is_preprint":false},{"year":2018,"finding":"CUX1 CUT domains stimulate APE1 (apurinic/apyrimidinic endonuclease 1) enzymatic activity in vitro; CUX1 knockdown decreases APE1 activity in cell extracts and increases abasic sites, while CUX1 overexpression has the opposite effect, promoting resistance to temozolomide.","method":"In vitro DNA repair assay with purified CUT domains and APE1, cell extract APE1 activity assay, abasic site quantification, CUX1 knockdown/overexpression in glioblastoma cells, clonogenic survival","journal":"Neuro-oncology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with purified proteins plus cell-based gain/loss-of-function; single lab with multiple orthogonal methods","pmids":["29036362"],"is_preprint":false},{"year":2017,"finding":"A recombinant protein containing only two CUT domains of CUX1 is sufficient for rapid recruitment to DNA damage sites, acceleration of base excision repair, and increased cell survival following ionizing radiation.","method":"CUT domain truncation experiments, DNA damage recruitment assay, clonogenic survival assay, OGG1 inhibitor treatment","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — domain truncation plus functional survival assay; single lab, two orthogonal approaches","pmids":["28147323"],"is_preprint":false},{"year":2021,"finding":"CUX1 recruits the histone methyltransferase EHMT2 to DNA double-strand breaks, promoting downstream H3K9 and H3K27 methylation, phosphorylated ATM retention, γH2AX focus formation and propagation, and 53BP1 recruitment, thereby mediating epigenetically driven DNA repair in hematopoietic stem and progenitor cells.","method":"CUX1-deficient mouse HSPCs, mechanistic epistasis analysis, γH2AX foci, 53BP1 recruitment assays, ChIP for histone marks at DNA breaks","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mechanistic dissection in primary HSPCs with multiple chromatin readouts; single lab","pmids":["34473231"],"is_preprint":false},{"year":2012,"finding":"CUX1 (p110 isoform) modulates constitutive expression of ATM, ATR, and DNA damage response genes; CUX1 knockdown reduces ATM/ATR expression and impairs ATM autophosphorylation, Chk2/p53 phosphorylation, γH2AX and Rad51 foci, and DNA strand break repair after IR and UV.","method":"Genome-wide ChIP-chip (promoter arrays), RNAi knockdown, genetic inactivation, Western blot for phosphorylation markers, DNA damage foci immunofluorescence, clonogenic survival, cell cycle checkpoint analysis","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genome-wide promoter binding plus RNAi and genetic KO with multiple damage-response readouts; single lab, multiple orthogonal methods","pmids":["22319212"],"is_preprint":false},{"year":2013,"finding":"CUX1 directly transcriptionally represses PIK3IP1 (a PI3K inhibitor); CUX1 deficiency leads to increased PI3K-AKT signaling and enhanced tumor growth, validating CUX1 as a tumor suppressor via the PI3K pathway.","method":"Transcriptional reporter assays, ChIP, Drosophila cancer models, mouse transposon insertional mutagenesis, PI3K/AKT inhibitor treatment of CUX1-mutant tumors","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct ChIP evidence for PIK3IP1 repression, cross-validated in multiple model organisms, with pharmacological rescue; replicated across systems","pmids":["24316979"],"is_preprint":false},{"year":2018,"finding":"CUX1 knockdown in human CD34+ cells decreases expression of PIK3IP1 (PI3K inhibitor) and elevates PI3K/AKT signaling, promoting HSC exit from quiescence and proliferation leading to HSC exhaustion; restoration of CUX1 expression reverses MDS disease in mice.","method":"shRNA mouse models with graded CUX1 knockdown, bone marrow transplantation, RNA-sequencing, functional HSC quiescence assays, PI3K signaling pathway analysis","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Moderate — graded shRNA mouse models with disease rescue, RNA-seq, and functional HSC assays; single lab, multiple orthogonal methods","pmids":["29592892"],"is_preprint":false},{"year":2021,"finding":"CUX1 directly represses the CFLAR (FLIP) promoter; CUX1 haploinsufficiency de-represses CFLAR, driving apoptosis evasion in AML cells. Genome-wide CRISPR/Cas9 screening identified CFLAR as a selective vulnerability in CUX1-deficient AML.","method":"Genome-wide CRISPR/Cas9 loss-of-function screen, CFLAR promoter ChIP and reporter assays, CUX1 knockdown/KO in murine and human AML cells, IAP antagonist treatment","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Moderate — CRISPR screen plus ChIP plus promoter reporter plus functional apoptosis assays; single lab, multiple orthogonal methods","pmids":["33931647"],"is_preprint":false},{"year":2022,"finding":"CUX1 binds to an atherosclerosis-associated SNP (rs1537371) in the CDKN2A/B locus and regulates expression of p14ARF, p15INK4b, p16INK4a, and ANRIL in endothelial cells; CUX1 induction triggers p16INK4a-dependent replicative and stress-induced senescence.","method":"Electrophoretic mobility shift assay (EMSA) for SNP binding, reporter assays, CUX1 knockdown/overexpression, senescence assays (β-galactosidase, p16 expression)","journal":"Nature aging","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — direct DNA binding to SNP with EMSA plus functional senescence assays; single lab, two orthogonal approaches","pmids":["37117763"],"is_preprint":false},{"year":2013,"finding":"CUX1 interacts with NF-κB p65 and recruits HDAC1 to chemokine promoters (e.g., CXCL10), reducing NF-κB p65 acetylation at K310 and repressing NF-κB-regulated cytokines in tumor-associated macrophages, thereby modulating M1 polarization.","method":"Co-immunoprecipitation, DNA pulldown, chromatin immunoprecipitation (ChIP), NF-κB reporter assay, CUX1 overexpression/knockdown in macrophages","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — Co-IP plus ChIP plus reporter assay plus functional cytokine profiling; single lab, multiple methods","pmids":["24336331"],"is_preprint":false},{"year":2020,"finding":"CUX1 and NF-κB p65 co-mediate transcription of CXCL1, CXCL2, and CXCL3 from a unique CUX1-NF-κB binding motif in their promoters in synovial fibroblasts responding to TNF + IL-17A; CUX1 knockdown selectively abolishes this synergistic cytokine response.","method":"Gene-silencing transcriptomics, siRNA knockdown, promoter binding motif analysis, transcription factor independence assays (LIFR, STAT3, STAT4, ELF3 ruled out)","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — transcriptomics plus targeted siRNA knockdown and promoter motif analysis; single lab, moderate mechanistic depth","pmids":["32079724"],"is_preprint":false},{"year":2010,"finding":"CUX1 (p110 and p75 isoforms) stimulates cell migration and invasion; siRNA knockdown of CUX1 reduces motility. CUX1 activates Snail and Slug transcription factors and cooperates with them to repress E-cadherin and occludin, disrupting cell-cell junctions. ChIP-chip identified >20 direct CUX1 target genes involved in cytoskeleton remodeling and Rho GTPase regulation.","method":"siRNA knockdown migration/invasion assays, ectopic expression experiments, ChIP-chip (promoter arrays), reporter assays for Snail/Slug/E-cadherin/occludin","journal":"Cell adhesion & migration","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — ChIP-chip plus migration/invasion assays plus reporter assays; single lab, multiple methods","pmids":["20224295"],"is_preprint":false},{"year":2010,"finding":"CUX1 in neurons transcriptionally represses p27(Kip1) expression to regulate dendritic complexity; this effect requires the DNA-binding domains of CUX1 and is mediated downstream via RhoA.","method":"CUX1 overexpression and knockdown in cortical neurons, quantitative morphological analysis of dendrites, reporter assays, dominant-negative and activated RhoA epistasis experiments","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — loss- and gain-of-function in neurons with pathway epistasis; single lab, partial mechanistic follow-up","pmids":["20485671"],"is_preprint":false},{"year":2010,"finding":"Cux1 and Cux2 regulate dendrite branching, spine development, and synapse formation in layer II-III cortical neurons partly through direct transcriptional regulation of chromatin remodeling genes Xlr3b and Xlr4b; knockout mice show reduced synaptic function and working memory deficits.","method":"Cux1/Cux2 knockout mice, shRNA knockdown, morphological analysis, electrophysiology, behavioral testing, gene expression analysis","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 2 / Strong — KO mice plus knockdown with morphological, electrophysiological, and behavioral readouts, replicated across two genes","pmids":["20510857"],"is_preprint":false},{"year":2002,"finding":"CDP/Cux C-terminus deletion (including the homeodomain) abolishes nuclear localization of the mutant protein and eliminates HiNF-D DNA binding activity in nuclear extracts; specific histone genes H4.1 and H1 containing CDP/Cux binding sites show reduced expression in homozygous mutant MEFs.","method":"Genetically targeted mouse (ΔC allele), indirect immunofluorescence, EMSA with nuclear extracts, Northern blot for histone genes","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo genetic model with direct localization and DNA binding assays; single lab, multiple readouts","pmids":["11839809"],"is_preprint":false},{"year":1999,"finding":"Cux/CDP is the identity component of NF-muNR and represses the immunoglobulin heavy chain intronic enhancer (Emu) by antagonizing the Bright transcription activator at matrix attachment regions (MARs), both at the DNA binding and functional levels.","method":"Expression library screening, EMSA supershift with Cux/CDP antiserum, cotransfection reporter assays, affinity-purified NF-muNR Western blot","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — EMSA supershift plus reporter assays plus biochemical identification; single lab, multiple methods","pmids":["9858552"],"is_preprint":false},{"year":2009,"finding":"Cux1 directly binds the p27(kip1) promoter in vivo and interacts with co-repressor Grg4 to enhance repression; ChIP assays show co-occupancy of Cux1, Grg4, HDAC1, and HDAC3 at two sites in the p27(kip1) promoter in newborn kidney tissue.","method":"Chromatin immunoprecipitation (ChIP) in kidney tissue, co-immunoprecipitation for Cux1-Grg4 interaction, promoter reporter (luciferase) assays, DNase I footprinting","journal":"Gene","confidence":"High","confidence_rationale":"Tier 2 / Moderate — in vivo ChIP in tissue plus Co-IP plus reporter plus footprinting; single lab, four orthogonal methods","pmids":["19332113"],"is_preprint":false},{"year":2008,"finding":"Sustained expression of p75-Cux1 isoform in transgenic mice causes polycystic kidneys; chromatin affinity purification confirmed direct binding of Cux1 to c-myc and p27 promoters, with upregulation of c-myc and downregulation of p27, increased cilia length, and elevated epithelial proliferation.","method":"Transgenic mouse model, chromatin affinity purification (ChAP), Western blot, immunohistochemistry, proliferation index","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — transgenic model plus ChAP for direct promoter occupancy; single lab, two methods","pmids":["18356167"],"is_preprint":false},{"year":2004,"finding":"SMAR1 and Cux/CDP physically interact with each other, co-localize in the perinuclear region, and independently repress the TCRbeta enhancer (Emu) via MARbeta; SMAR1 repressor activity is strongly enhanced in the presence of Cux/CDP. Overexpression of both proteins modulates chromatin structure at MARbeta as shown by DNase I hypersensitivity.","method":"Co-immunoprecipitation for SMAR1-Cux/CDP interaction, immunofluorescence colocalization, reporter gene cotransfection assays, DNase I hypersensitivity","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — Co-IP plus reporter assays plus chromatin structure analysis; single lab, multiple methods","pmids":["15371550"],"is_preprint":false},{"year":1997,"finding":"CDP/Cut (CUX1) binds to a silencer element in the lactoferrin promoter (identified as a ~180 kDa protein by UV cross-linking/EMSA) in non-LF-expressing hematopoietic cells; CDP/cut overexpression blocks lactoferrin expression upon granulocyte colony-stimulating factor-induced neutrophil maturation.","method":"Luciferase reporter transfections, EMSA, UV cross-linking, Western blot identification, overexpression in myeloid stem cells","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — EMSA plus UV cross-linking identification plus functional reporter and overexpression assays; single lab","pmids":["9326246"],"is_preprint":false},{"year":2020,"finding":"Cathepsin L proteolytically processes CDP/Cux (CUX1) to produce the p110 isoform in gastric cancer; p110 then stably binds the VEGF-D promoter and activates VEGF-D transcription, promoting tumor angiogenesis.","method":"Western blot for p110 generation, co-immunoprecipitation of CTSL and CUX1, dual-luciferase reporter assay for VEGF-D promoter, endothelial tube formation/HUVEC migration, CAM assay","journal":"Gastric cancer","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — biochemical processing assay plus reporter plus functional angiogenesis assays; single lab, multiple methods","pmids":["32388635"],"is_preprint":false},{"year":2018,"finding":"Ionizing radiation reduces GSK-3β activity via CTSL-mediated phosphorylation of Ser9; CTSL also processes CUX1 to the p110 isoform, which then promotes EMT and increases glioma cell migration and invasion.","method":"Western blot for GSK-3β phosphorylation, CTSL overexpression/knockdown, CUX1 processing assay, migration/invasion assays","journal":"Cellular signalling","confidence":"Low","confidence_rationale":"Tier 3 / Weak — Western blot-based mechanistic claims; single lab, single-method per step","pmids":["29331585"],"is_preprint":false},{"year":2014,"finding":"CUX1 and GLIS1 cooperate to stimulate TCF/β-catenin transcriptional activity and enhance cell migration and invasion; co-expression experiments in breast cancer model demonstrate their joint activation of Wnt pathway target genes.","method":"TCF/β-catenin reporter assay, co-expression experiments, Wnt inhibitor (FZD/LRP receptor inhibitors), laser-capture microdissection gene expression profiling","journal":"Biology open","confidence":"Low","confidence_rationale":"Tier 3 / Weak — reporter assay and co-expression with pharmacological inhibition; single lab, limited mechanistic resolution","pmids":["25217618"],"is_preprint":false},{"year":1992,"finding":"Clox (mammalian CUX1/CDP) proteins are nuclear DNA-binding proteins with sequence specificity similar to Drosophila Cut; cotransfection experiments demonstrate they function as repressors of tissue-specific gene transcription.","method":"cDNA cloning, Western blot, EMSA, cotransfection transcription repression assays","journal":"Development (Cambridge, England)","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — EMSA plus cotransfection reporter assays; foundational characterization with two orthogonal methods","pmids":["1363085"],"is_preprint":false},{"year":2004,"finding":"CUX1 in SVZ precursor cells shows nuclear localization in BrdU-positive dividing SVZ cells but weak diffuse localization in VZ cells, suggesting CUX1 function is first activated in SVZ intermediate progenitors.","method":"Immunofluorescence with anti-Cux-1 antibody, BrdU labeling, Pax-6 null mutation analysis","journal":"The Journal of comparative neurology","confidence":"Low","confidence_rationale":"Tier 3 / Weak — immunofluorescence localization study without direct functional consequence experiment for this specific finding","pmids":["15452856"],"is_preprint":false},{"year":2004,"finding":"Cux-1 is significantly upregulated downstream of constitutively active Notch 1 signaling in rat kidney epithelial cells, and Cux1 interacts with the Groucho homolog TLE-4 co-repressor (which is recruited by Notch effector proteins), linking CUX1 to the Notch pathway.","method":"Constitutively active Notch 1 overexpression in RKE cells, Western blot, co-immunoprecipitation of Cux1 with TLE-4","journal":"Developmental dynamics","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single Co-IP and overexpression experiment; single lab, limited mechanistic depth","pmids":["15499562"],"is_preprint":false},{"year":1997,"finding":"Cux/CDP binds to the c-mos upstream enhancer site III via Cut repeat CR3 and the homeodomain (both required for efficient binding) and represses c-mos enhancer activity in cotransfection assays.","method":"GST-fusion protein pull-down with deletion mutants, EMSA supershift with anti-hCut antibodies, CAT reporter cotransfection assays","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — domain mapping with deletion mutants plus EMSA supershift plus reporter assay; single lab, three methods","pmids":["9130595"],"is_preprint":false}],"current_model":"CUX1 encodes multiple isoforms (p200/full-length, p110, p90, p75) generated by proteolytic processing via nuclear cathepsin L and/or alternative transcription initiation; the p110 isoform, whose DNA binding is activated at G1/S by Cdc25A dephosphorylation and then inhibited in G2 by cyclin A-Cdk1 phosphorylation at S1237/S1270, acts as a cell-cycle-dependent transcriptional activator (e.g., DNA pol-α, Ect2/MgcRacGAP/MKLP1) and repressor (p21, p27, PIK3IP1, CFLAR, CXCL1-3) through its CUT domains and homeodomain; additionally, the CUT domains function as ancillary factors that directly stimulate OGG1 and APE1 enzymatic activities to accelerate base excision repair and, together with recruited EHMT2-driven histone methylation, orchestrate the DNA damage response, while CUX1 also interacts with NF-κB p65 (recruiting HDAC1) and co-repressors Grg4/TLE-4 to modulate inflammation and development, and haploinsufficiency of CUX1 de-represses PIK3IP1 and CFLAR, activating PI3K-AKT signaling and promoting apoptosis evasion in myeloid neoplasms."},"narrative":{"mechanistic_narrative":"CUX1 (CDP/Cut) is a homeodomain transcription factor that uses CUT-repeat and homeodomain DNA-binding modules to control gene programs governing cell-cycle progression, the DNA damage response, and tissue development, and that functions as a haploinsufficient tumor suppressor [PMID:12665598, PMID:24618719, PMID:24316979]. Multiple functional isoforms are produced from the full-length p200 protein: nuclear cathepsin L proteolytically processes CUX1 during the G1/S transition to generate the stably DNA-binding p110 (and p90) isoform [PMID:15099520, PMID:16972798], while a shorter p75 isoform arises from transcription initiation within intron 20 [PMID:12438259]. The DNA-binding activity of p110 is cell-cycle gated — activated at G1/S by Cdc25A dephosphorylation and processing [PMID:11403998], then inhibited in G2 by cyclin A-Cdk1 phosphorylation at S1237/S1270 [PMID:11584018]. Functionally, CUX1 acts as both an activator and a repressor: it activates the DNA polymerase alpha promoter in S phase [PMID:12665598], cooperates with E2F1 to drive G2/M expression of the cytokinesis genes Ect2, MgcRacGAP, and MKLP1 [PMID:19015243], and represses cell-cycle inhibitors including p21 [PMID:11584018] and p27(Kip1), the latter via recruitment of the co-repressor Grg4 with HDAC1/HDAC3 [PMID:19332113, PMID:20485671]. Independent of transcription, the CUT domains act as ancillary base-excision-repair factors that directly stimulate OGG1 and APE1 enzymatic activity and are rapidly recruited to damage sites to accelerate repair [PMID:24618719, PMID:29036362, PMID:28147323], while CUX1 also transcriptionally sustains ATM/ATR expression and recruits the histone methyltransferase EHMT2 to double-strand breaks to drive H3K9/H3K27 methylation and 53BP1 recruitment [PMID:22319212, PMID:34473231]. As a tumor suppressor, CUX1 directly represses the PI3K inhibitor PIK3IP1 and the apoptosis regulator CFLAR, such that CUX1 haploinsufficiency de-represses these targets, activating PI3K-AKT signaling and promoting apoptosis evasion in myeloid neoplasms [PMID:24316979, PMID:29592892, PMID:33931647]. CUX1 additionally partners with NF-κB p65 to modulate chemokine transcription in inflammation [PMID:24336331, PMID:32079724] and, with Cux2, regulates dendritic and synaptic development in cortical neurons [PMID:20510857].","teleology":[{"year":1992,"claim":"Established the founding biochemical identity of mammalian CUX1 as a sequence-specific nuclear DNA-binding protein related to Drosophila Cut that represses tissue-specific transcription.","evidence":"cDNA cloning, EMSA, and cotransfection repression assays","pmids":["1363085"],"confidence":"Medium","gaps":["No isoform structure or cell-cycle regulation defined","Direct target genes not yet mapped"]},{"year":1997,"claim":"Defined how CUX1 contacts DNA and represses targets, showing CUT repeat CR3 plus the homeodomain are both required for binding, and linked CUX1 to repression of myeloid maturation genes.","evidence":"GST pulldown domain mapping, EMSA supershift, and reporter assays on c-mos and lactoferrin promoters","pmids":["9130595","9326246"],"confidence":"Medium","gaps":["Did not address isoform-specific binding","No genome-wide target identification"]},{"year":2001,"claim":"Resolved how CUX1 DNA binding is gated across the cell cycle, showing G1/S activation by Cdc25A dephosphorylation and processing, and G2 inhibition by cyclin A-Cdk1 phosphorylation at S1237/S1270 that relieves p21 repression.","evidence":"Cell synchronization, EMSA, in vitro kinase/binding assays, S1237A/S1270A mutagenesis, and reporter assays","pmids":["11403998","11584018"],"confidence":"High","gaps":["Identity of the processing protease not established here","Did not address activator function"]},{"year":2002,"claim":"Demonstrated isoform diversification by identifying the p75 isoform from intronic transcription initiation and confirming CUX1 DNA binding and nuclear localization require the C-terminal homeodomain in vivo.","evidence":"Isoform characterization, reporter assays, transgenic/targeted mouse models, and EMSA","pmids":["12438259","11839809"],"confidence":"Medium","gaps":["Mechanism generating p110 still unresolved","Physiological relevance of histone gene targets unclear"]},{"year":2003,"claim":"Revealed that processed N-terminally truncated CUX1 acts as a transcriptional activator, not just repressor, occupying the DNA polymerase alpha promoter specifically in S phase.","evidence":"ChIP, reporter assays, retroviral expression, and linker scanning","pmids":["12665598"],"confidence":"High","gaps":["Determinants of activator vs repressor switching not defined","Cofactors for activation unknown"]},{"year":2004,"claim":"Identified nuclear cathepsin L as the protease that generates the p110 isoform during G1/S, providing the mechanistic basis for cell-cycle-coupled CUX1 activation.","evidence":"Cathepsin L knockout cells, ectopic expression, activity-based probes, and in situ processing assays","pmids":["15099520"],"confidence":"High","gaps":["Cleavage site not precisely mapped here","Regulation of nuclear cathepsin L entry incompletely defined"]},{"year":2004,"claim":"Connected CUX1 to developmental signaling and chromatin-anchoring repression, linking it to Notch via TLE-4 and to matrix-attachment-region repression via SMAR1.","evidence":"Co-IP, immunofluorescence colocalization, and reporter assays in kidney and lymphoid models","pmids":["15499562","15371550"],"confidence":"Low","gaps":["TLE-4 link rests on a single Co-IP and overexpression","Functional consequences of SMAR1 interaction in vivo unclear"]},{"year":2006,"claim":"Mapped the cathepsin L-generated p90 isoform N-terminus and showed it shares DNA-binding and transcriptional activity with p110, refining the processing model.","evidence":"Deletion-mutant mapping and co-expression with active cathepsin L isoforms","pmids":["16972798"],"confidence":"Medium","gaps":["Distinct in vivo roles of p90 vs p110 not separated"]},{"year":2008,"claim":"Extended CUX1 activator function into mitosis, showing cooperation with E2F1 to drive G2/M expression of cytokinesis genes Ect2, MgcRacGAP, and MKLP1.","evidence":"ChIP, promoter-luciferase assays, siRNA knockdown, and dominant-negative expression","pmids":["19015243"],"confidence":"High","gaps":["Direct physical CUX1-E2F1 complex not structurally defined"]},{"year":2009,"claim":"Established a co-repressor mechanism for p27(Kip1) repression in vivo, showing Cux1 recruits Grg4 with HDAC1/HDAC3 to the promoter in kidney tissue.","evidence":"In vivo ChIP, Co-IP, reporter assays, and DNase I footprinting","pmids":["19332113"],"confidence":"High","gaps":["Generality across tissues not addressed"]},{"year":2010,"claim":"Defined developmental and pro-invasive roles, showing Cux1/Cux2 control dendrite and synapse formation via Xlr3b/Xlr4b, that CUX1 represses p27 to regulate dendrite complexity through RhoA, and that CUX1 promotes EMT/invasion via Snail/Slug.","evidence":"Knockout mice, electrophysiology, behavior, neuronal gain/loss-of-function, ChIP-chip, and invasion assays","pmids":["20510857","20485671","20224295"],"confidence":"High","gaps":["Isoform contributions to neuronal phenotypes not separated","Pro-invasive role context dependence unclear"]},{"year":2012,"claim":"Showed CUX1 broadly sustains the DNA damage response by transcriptionally maintaining ATM/ATR expression, with knockdown impairing checkpoint signaling and repair.","evidence":"Genome-wide ChIP-chip, RNAi, genetic inactivation, damage foci imaging, and clonogenic survival","pmids":["22319212"],"confidence":"High","gaps":["Did not yet distinguish transcriptional from direct repair roles"]},{"year":2013,"claim":"Defined CUX1 as a haploinsufficient tumor suppressor acting through PI3K, showing direct repression of PIK3IP1 such that CUX1 loss activates PI3K-AKT and enhances tumor growth, and revealing NF-κB-coupled inflammatory repression.","evidence":"ChIP, reporter assays, Drosophila and mouse transposon models, pharmacological PI3K inhibition, and macrophage Co-IP/ChIP","pmids":["24316979","24336331"],"confidence":"High","gaps":["Full set of haploinsufficiency-relevant targets incomplete","NF-κB mechanism is Medium-confidence single lab"]},{"year":2014,"claim":"Established a non-transcriptional repair function, showing CUX1 CUT domains directly stimulate OGG1 to accelerate 8-oxoG base excision repair and prevent RAS-induced senescence.","evidence":"In vitro repair reconstitution with purified proteins, comet assays in Cux1+/- MEFs, and a transgenic mouse model","pmids":["24618719"],"confidence":"High","gaps":["Structural basis of CUT domain-OGG1 stimulation undefined"]},{"year":2018,"claim":"Generalized the ancillary-repair mechanism to APE1, showing CUT domains stimulate APE1 activity and that CUX1 levels set abasic-site burden and chemoresistance in glioblastoma.","evidence":"In vitro repair assays with purified CUT domains and APE1, cell extract activity assays, and clonogenic survival with temozolomide","pmids":["29036362"],"confidence":"High","gaps":["Whether CUT domains act on additional BER enzymes unknown"]},{"year":2017,"claim":"Showed a minimal two-CUT-domain fragment is sufficient for rapid recruitment to damage sites and radioprotection, isolating the repair function from full-length CUX1.","evidence":"CUT domain truncation, damage recruitment assays, OGG1 inhibition, and clonogenic survival","pmids":["28147323"],"confidence":"Medium","gaps":["Recruitment mechanism to lesions not defined"]},{"year":2018,"claim":"Linked radiation signaling to CUX1 processing, proposing CTSL-mediated p110 generation drives glioma EMT and invasion.","evidence":"Western blot of GSK-3β phosphorylation, CTSL gain/loss-of-function, processing assay, and invasion assays","pmids":["29331585"],"confidence":"Low","gaps":["Mechanistic claims rest largely on single-method Western blots","Causal chain from GSK-3β to CUX1 to EMT not established"]},{"year":2020,"claim":"Extended CUX1-NF-κB cooperation to a defined promoter motif, showing CUX1 is required for synergistic CXCL1-3 induction by TNF + IL-17A in synovial fibroblasts, and showed cathepsin L-generated p110 activates VEGF-D to promote angiogenesis.","evidence":"Silencing transcriptomics, siRNA, motif analysis, processing assays, and angiogenesis assays","pmids":["32079724","32388635"],"confidence":"Medium","gaps":["Direct CUX1-p65 complex composition at chemokine promoters incompletely defined"]},{"year":2021,"claim":"Connected the repair and tumor-suppressor roles in hematopoiesis, showing CUX1 recruits EHMT2 to double-strand breaks for epigenetic repair and represses CFLAR, with haploinsufficiency creating apoptosis evasion and a targetable CFLAR vulnerability in AML.","evidence":"CUX1-deficient mouse HSPCs, ChIP for histone marks, gamma-H2AX/53BP1 assays, genome-wide CRISPR screen, CFLAR ChIP/reporter, and IAP antagonist treatment","pmids":["34473231","33931647"],"confidence":"Medium","gaps":["Order of EHMT2 recruitment relative to other repair factors not fully resolved","CFLAR study single lab"]},{"year":2022,"claim":"Implicated CUX1 in vascular aging, showing it binds an atherosclerosis-associated SNP in the CDKN2A/B locus and triggers p16INK4a-dependent endothelial senescence.","evidence":"EMSA for SNP binding, reporter assays, gain/loss-of-function, and senescence assays","pmids":["37117763"],"confidence":"Medium","gaps":["Genotype-specific effect on disease risk not directly tested in vivo"]},{"year":null,"claim":"How the same CUT/homeodomain modules are partitioned between transcription and direct enzymatic stimulation of repair enzymes, and what dictates isoform- and context-specific activator-vs-repressor outputs, remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model of CUT domain engagement with OGG1/APE1 or DNA","Determinants switching CUX1 between activation and repression undefined","Mechanism of recruitment to DNA damage sites not established"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[3,21,30,33,15]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[3,6,12,14,23,30]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[7,8,9]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,21,30,31]},{"term_id":"GO:0005654","term_label":"nucleoplasm","supporting_discovery_ids":[10,11,23]}],"pathway":[{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[2,3,6]},{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[7,8,9,10,11]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[3,12,14,23,30]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[12,13]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[15,7]}],"complexes":[],"partners":["CTSL","E2F1","RELA","EHMT2","OGG1","APE1","TLE4","HDAC1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P39880","full_name":"Homeobox protein cut-like 1","aliases":["CCAAT displacement protein","CDP","CDP/Cux p200","Homeobox protein cux-1"],"length_aa":1505,"mass_kda":164.2,"function":"Transcription factor involved in the control of neuronal differentiation in the brain. Regulates dendrite development and branching, and dendritic spine formation in cortical layers II-III. Also involved in the control of synaptogenesis. In addition, it has probably a broad role in mammalian development as a repressor of developmentally regulated gene expression. May act by preventing binding of positively-activing CCAAT factors to promoters. Component of nf-munr repressor; binds to the matrix attachment regions (MARs) (5' and 3') of the immunoglobulin heavy chain enhancer. Represses T-cell receptor (TCR) beta enhancer function by binding to MARbeta, an ATC-rich DNA sequence located upstream of the TCR beta enhancer. Binds to the TH enhancer; may require the basic helix-loop-helix protein TCF4 as a coactivator Plays a role in cell cycle progression, in particular at the G1/S transition. As cells progress into S phase, a fraction of CUX1 molecules is proteolytically processed into N-terminally truncated proteins of 110 kDa. While CUX1 only transiently binds to DNA and carries the CCAAT-displacement activity, CDP/Cux p110 makes a stable interaction with DNA and stimulates expression of genes such as POLA1","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/P39880/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CUX1","classification":"Not Classified","n_dependent_lines":6,"n_total_lines":1208,"dependency_fraction":0.004966887417218543},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"HDAC1","stoichiometry":0.2},{"gene":"RAB1A","stoichiometry":0.2},{"gene":"RAB1B","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/CUX1","total_profiled":1310},"omim":[{"mim_id":"619417","title":"TRIPARTITE MOTIF-CONTAINING PROTEIN 61; TRIM61","url":"https://www.omim.org/entry/619417"},{"mim_id":"618476","title":"BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS","url":"https://www.omim.org/entry/618476"},{"mim_id":"618330","title":"NEURODEVELOPMENTAL DISORDER WITH DEVELOPMENTAL DELAY AND WITH OR WITHOUT MOTOR OR SPEECH DELAY; NEDDMS","url":"https://www.omim.org/entry/618330"},{"mim_id":"617600","title":"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 45; MRD45","url":"https://www.omim.org/entry/617600"},{"mim_id":"612082","title":"CAPICUA TRANSCRIPTIONAL REPRESSOR; CIC","url":"https://www.omim.org/entry/612082"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Golgi apparatus","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/CUX1"},"hgnc":{"alias_symbol":["CDP","CDP1","CUX","CUT","Clox","CDP/Cut","CDP/Cux","Cux/CDP","CASP","GOLIM6"],"prev_symbol":["CUTL1"]},"alphafold":{"accession":"P39880","domains":[{"cath_id":"1.10.260.40","chopping":"554-630","consensus_level":"high","plddt":88.0858,"start":554,"end":630},{"cath_id":"1.10.260.40","chopping":"933-1008","consensus_level":"high","plddt":89.022,"start":933,"end":1008},{"cath_id":"1.10.260.40","chopping":"1116-1213","consensus_level":"medium","plddt":87.681,"start":1116,"end":1213},{"cath_id":"1.10.10.60","chopping":"1251-1309","consensus_level":"medium","plddt":87.29,"start":1251,"end":1309}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P39880","model_url":"https://alphafold.ebi.ac.uk/files/AF-P39880-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P39880-F1-predicted_aligned_error_v6.png","plddt_mean":61.25},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CUX1","jax_strain_url":"https://www.jax.org/strain/search?query=CUX1"},"sequence":{"accession":"P39880","fasta_url":"https://rest.uniprot.org/uniprotkb/P39880.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P39880/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P39880"}},"corpus_meta":[{"pmid":"31036827","id":"PMC_31036827","title":"CUT&Tag for efficient epigenomic profiling of small samples and single cells.","date":"2019","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/31036827","citation_count":1689,"is_preprint":false},{"pmid":"18809224","id":"PMC_18809224","title":"MMEJ repair of double-strand breaks (director's cut): deleted sequences and alternative endings.","date":"2008","source":"Trends in genetics : TIG","url":"https://pubmed.ncbi.nlm.nih.gov/18809224","citation_count":736,"is_preprint":false},{"pmid":"15452856","id":"PMC_15452856","title":"Expression of Cux-1 and Cux-2 in the subventricular zone and upper layers II-IV of the cerebral cortex.","date":"2004","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/15452856","citation_count":417,"is_preprint":false},{"pmid":"16129881","id":"PMC_16129881","title":"Regulating cell migration: calpains make the cut.","date":"2005","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/16129881","citation_count":396,"is_preprint":false},{"pmid":"31232687","id":"PMC_31232687","title":"Improved CUT&RUN chromatin profiling tools.","date":"2019","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/31232687","citation_count":393,"is_preprint":false},{"pmid":"33846645","id":"PMC_33846645","title":"Single-cell CUT&Tag profiles histone modifications and transcription factors in complex tissues.","date":"2021","source":"Nature biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/33846645","citation_count":362,"is_preprint":false},{"pmid":"32913232","id":"PMC_32913232","title":"Efficient low-cost chromatin profiling with CUT&Tag.","date":"2020","source":"Nature protocols","url":"https://pubmed.ncbi.nlm.nih.gov/32913232","citation_count":334,"is_preprint":false},{"pmid":"15099520","id":"PMC_15099520","title":"A cathepsin L isoform that is devoid of a signal peptide localizes to the nucleus in S phase and processes the CDP/Cux transcription factor.","date":"2004","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/15099520","citation_count":303,"is_preprint":false},{"pmid":"35143307","id":"PMC_35143307","title":"Spatial-CUT&Tag: Spatially resolved chromatin modification profiling at the cellular level.","date":"2022","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/35143307","citation_count":265,"is_preprint":false},{"pmid":"20510857","id":"PMC_20510857","title":"Cux1 and Cux2 regulate dendritic branching, spine morphology, and synapses of the upper layer neurons of the cortex.","date":"2010","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/20510857","citation_count":247,"is_preprint":false},{"pmid":"23010477","id":"PMC_23010477","title":"Phosphatidylcholine and the CDP-choline cycle.","date":"2012","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/23010477","citation_count":217,"is_preprint":false},{"pmid":"11403998","id":"PMC_11403998","title":"Role of the multifunctional CDP/Cut/Cux homeodomain transcription factor in regulating differentiation, cell growth and development.","date":"2001","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/11403998","citation_count":201,"is_preprint":false},{"pmid":"34792172","id":"PMC_34792172","title":"Genome-wide mapping of G-quadruplex structures with CUT&Tag.","date":"2022","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/34792172","citation_count":152,"is_preprint":false},{"pmid":"33846646","id":"PMC_33846646","title":"Single-cell CUT&Tag analysis of chromatin modifications in differentiation and tumor progression.","date":"2021","source":"Nature biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/33846646","citation_count":146,"is_preprint":false},{"pmid":"7869846","id":"PMC_7869846","title":"Metabolism and actions of CDP-choline as an endogenous compound and administered exogenously as citicoline.","date":"1995","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/7869846","citation_count":144,"is_preprint":false},{"pmid":"37316672","id":"PMC_37316672","title":"Genome editing of a rice CDP-DAG synthase confers multipathogen resistance.","date":"2023","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/37316672","citation_count":136,"is_preprint":false},{"pmid":"31709724","id":"PMC_31709724","title":"Therapeutic targeting of circ-CUX1/EWSR1/MAZ axis inhibits glycolysis and neuroblastoma progression.","date":"2019","source":"EMBO molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31709724","citation_count":133,"is_preprint":false},{"pmid":"9695827","id":"PMC_9695827","title":"Fission yeast cut mutations revisited: control of anaphase.","date":"1998","source":"Trends in cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/9695827","citation_count":132,"is_preprint":false},{"pmid":"23212519","id":"PMC_23212519","title":"CUX1 is a haploinsufficient tumor suppressor gene on chromosome 7 frequently inactivated in acute myeloid leukemia.","date":"2012","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/23212519","citation_count":129,"is_preprint":false},{"pmid":"18313863","id":"PMC_18313863","title":"The multiple roles of CUX1: insights from mouse models and cell-based assays.","date":"2008","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/18313863","citation_count":127,"is_preprint":false},{"pmid":"8709678","id":"PMC_8709678","title":"CDP-choline: pharmacological and clinical review.","date":"1995","source":"Methods and findings in experimental and clinical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/8709678","citation_count":121,"is_preprint":false},{"pmid":"16126385","id":"PMC_16126385","title":"Microtubules cut and run.","date":"2005","source":"Trends in cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/16126385","citation_count":118,"is_preprint":false},{"pmid":"24316979","id":"PMC_24316979","title":"Inactivating CUX1 mutations promote tumorigenesis.","date":"2013","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24316979","citation_count":109,"is_preprint":false},{"pmid":"1363085","id":"PMC_1363085","title":"Clox, a mammalian homeobox gene related to Drosophila cut, encodes DNA-binding regulatory proteins differentially expressed during development.","date":"1992","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/1363085","citation_count":104,"is_preprint":false},{"pmid":"31500663","id":"PMC_31500663","title":"CUT&RUNTools: a flexible pipeline for CUT&RUN processing and footprint analysis.","date":"2019","source":"Genome biology","url":"https://pubmed.ncbi.nlm.nih.gov/31500663","citation_count":104,"is_preprint":false},{"pmid":"8602527","id":"PMC_8602527","title":"Switching from cut-and-paste to replicative Tn7 transposition.","date":"1996","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/8602527","citation_count":102,"is_preprint":false},{"pmid":"36536148","id":"PMC_36536148","title":"Multimodal chromatin profiling using nanobody-based single-cell CUT&Tag.","date":"2022","source":"Nature biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/36536148","citation_count":97,"is_preprint":false},{"pmid":"25190083","id":"PMC_25190083","title":"CUX1, a haploinsufficient tumour suppressor gene overexpressed in advanced cancers.","date":"2014","source":"Nature reviews. Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/25190083","citation_count":93,"is_preprint":false},{"pmid":"11839809","id":"PMC_11839809","title":"Genetic ablation of the CDP/Cux protein C terminus results in hair cycle defects and reduced male fertility.","date":"2002","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/11839809","citation_count":93,"is_preprint":false},{"pmid":"17673461","id":"PMC_17673461","title":"The CDP-ethanolamine pathway and phosphatidylserine decarboxylation generate different phosphatidylethanolamine molecular species.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17673461","citation_count":89,"is_preprint":false},{"pmid":"20442202","id":"PMC_20442202","title":"CUX1: target of Akt signalling and mediator of resistance to apoptosis in pancreatic cancer.","date":"2010","source":"Gut","url":"https://pubmed.ncbi.nlm.nih.gov/20442202","citation_count":87,"is_preprint":false},{"pmid":"32117988","id":"PMC_32117988","title":"CDP-Diacylglycerol Synthases (CDS): Gateway to Phosphatidylinositol and Cardiolipin Synthesis.","date":"2020","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/32117988","citation_count":86,"is_preprint":false},{"pmid":"32079724","id":"PMC_32079724","title":"CUX1 and IκBζ (NFKBIZ) mediate the synergistic inflammatory response to TNF and IL-17A in stromal fibroblasts.","date":"2020","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/32079724","citation_count":73,"is_preprint":false},{"pmid":"28275684","id":"PMC_28275684","title":"Thymic Stromal Lymphopoietin: To Cut a Long Story Short.","date":"2017","source":"Cellular and molecular gastroenterology and hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/28275684","citation_count":70,"is_preprint":false},{"pmid":"34663924","id":"PMC_34663924","title":"Automated CUT&Tag profiling of chromatin heterogeneity in mixed-lineage leukemia.","date":"2021","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/34663924","citation_count":69,"is_preprint":false},{"pmid":"8798433","id":"PMC_8798433","title":"Primary structure, neural-specific expression, and chromosomal localization of Cux-2, a second murine homeobox gene related to Drosophila cut.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8798433","citation_count":69,"is_preprint":false},{"pmid":"9858552","id":"PMC_9858552","title":"Cux/CDP homeoprotein is a component of NF-muNR and represses the immunoglobulin heavy chain intronic enhancer by antagonizing the bright transcription activator.","date":"1999","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9858552","citation_count":68,"is_preprint":false},{"pmid":"22306263","id":"PMC_22306263","title":"CUX1 transcription factors: from biochemical activities and cell-based assays to mouse models and human diseases.","date":"2012","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/22306263","citation_count":65,"is_preprint":false},{"pmid":"9370321","id":"PMC_9370321","title":"CDP-choline:1,2-diacylglycerol cholinephosphotransferase.","date":"1997","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/9370321","citation_count":63,"is_preprint":false},{"pmid":"12665598","id":"PMC_12665598","title":"CDP/Cux stimulates transcription from the DNA polymerase alpha gene promoter.","date":"2003","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12665598","citation_count":61,"is_preprint":false},{"pmid":"34579723","id":"PMC_34579723","title":"p113 isoform encoded by CUX1 circular RNA drives tumor progression via facilitating ZRF1/BRD4 transactivation.","date":"2021","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/34579723","citation_count":60,"is_preprint":false},{"pmid":"12438259","id":"PMC_12438259","title":"Characterization of a tissue-specific CDP/Cux isoform, p75, activated in breast tumor cells.","date":"2002","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/12438259","citation_count":60,"is_preprint":false},{"pmid":"24618719","id":"PMC_24618719","title":"RAS transformation requires CUX1-dependent repair of oxidative DNA damage.","date":"2014","source":"PLoS biology","url":"https://pubmed.ncbi.nlm.nih.gov/24618719","citation_count":57,"is_preprint":false},{"pmid":"9326246","id":"PMC_9326246","title":"CCAAT displacement protein (CDP/cut) recognizes a silencer element within the lactoferrin gene promoter.","date":"1997","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/9326246","citation_count":53,"is_preprint":false},{"pmid":"20485671","id":"PMC_20485671","title":"The transcription factor Cux1 regulates dendritic morphology of cortical pyramidal neurons.","date":"2010","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/20485671","citation_count":52,"is_preprint":false},{"pmid":"31671185","id":"PMC_31671185","title":"Making the cut(s): how Cas12a cleaves target and non-target DNA.","date":"2019","source":"Biochemical Society transactions","url":"https://pubmed.ncbi.nlm.nih.gov/31671185","citation_count":51,"is_preprint":false},{"pmid":"25059644","id":"PMC_25059644","title":"Cux1 and Cux2 selectively target basal and apical dendritic compartments of layer II-III cortical neurons.","date":"2014","source":"Developmental neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/25059644","citation_count":51,"is_preprint":false},{"pmid":"34244724","id":"PMC_34244724","title":"CUT&RUNTools 2.0: a pipeline for single-cell and bulk-level CUT&RUN and CUT&Tag data analysis.","date":"2021","source":"Bioinformatics (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/34244724","citation_count":50,"is_preprint":false},{"pmid":"11584018","id":"PMC_11584018","title":"Phosphorylation of the CCAAT displacement protein (CDP)/Cux transcription factor by cyclin A-Cdk1 modulates its DNA binding activity in G(2).","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11584018","citation_count":50,"is_preprint":false},{"pmid":"29592892","id":"PMC_29592892","title":"Gene dosage effect of CUX1 in a murine model disrupts HSC homeostasis and controls the severity and mortality of MDS.","date":"2018","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/29592892","citation_count":46,"is_preprint":false},{"pmid":"18327765","id":"PMC_18327765","title":"Cux-1 and Cux-2 control the development of Reelin expressing cortical interneurons.","date":"2008","source":"Developmental neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/18327765","citation_count":45,"is_preprint":false},{"pmid":"15474416","id":"PMC_15474416","title":"Transcription and DNA adducts: what happens when the message gets cut off?","date":"2004","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/15474416","citation_count":45,"is_preprint":false},{"pmid":"22319212","id":"PMC_22319212","title":"CUX1 transcription factor is required for optimal ATM/ATR-mediated responses to DNA damage.","date":"2012","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/22319212","citation_count":45,"is_preprint":false},{"pmid":"16419078","id":"PMC_16419078","title":"Expression of Cux-1 and Cux-2 in the developing somatosensory cortex of normal and barrel-defective mice.","date":"2006","source":"The anatomical record. Part A, Discoveries in molecular, cellular, and evolutionary biology","url":"https://pubmed.ncbi.nlm.nih.gov/16419078","citation_count":44,"is_preprint":false},{"pmid":"19015243","id":"PMC_19015243","title":"CUX1 and E2F1 regulate coordinated expression of the mitotic complex genes Ect2, MgcRacGAP, and MKLP1 in S phase.","date":"2008","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/19015243","citation_count":43,"is_preprint":false},{"pmid":"25217618","id":"PMC_25217618","title":"Autocrine Activation of the Wnt/β-Catenin Pathway by CUX1 and GLIS1 in Breast Cancers.","date":"2014","source":"Biology open","url":"https://pubmed.ncbi.nlm.nih.gov/25217618","citation_count":40,"is_preprint":false},{"pmid":"16023307","id":"PMC_16023307","title":"Isolation and characterization of murine Cds (CDP-diacylglycerol synthase) 1 and 2.","date":"2005","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/16023307","citation_count":40,"is_preprint":false},{"pmid":"20689760","id":"PMC_20689760","title":"Glutamate receptor GRIA3--target of CUX1 and mediator of tumor progression in pancreatic cancer.","date":"2010","source":"Neoplasia (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/20689760","citation_count":39,"is_preprint":false},{"pmid":"34824276","id":"PMC_34824276","title":"AGPAT2 interaction with CDP-diacylglycerol synthases promotes the flux of fatty acids through the CDP-diacylglycerol pathway.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/34824276","citation_count":38,"is_preprint":false},{"pmid":"32360136","id":"PMC_32360136","title":"CDP-diacylglycerol, a critical intermediate in lipid metabolism.","date":"2020","source":"Chemistry and physics of lipids","url":"https://pubmed.ncbi.nlm.nih.gov/32360136","citation_count":38,"is_preprint":false},{"pmid":"24336331","id":"PMC_24336331","title":"CUX1 modulates polarization of tumor-associated macrophages by antagonizing NF-κB signaling.","date":"2013","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/24336331","citation_count":38,"is_preprint":false},{"pmid":"31320321","id":"PMC_31320321","title":"Distinct clinical and biological implications of CUX1 in myeloid neoplasms.","date":"2019","source":"Blood advances","url":"https://pubmed.ncbi.nlm.nih.gov/31320321","citation_count":36,"is_preprint":false},{"pmid":"15371550","id":"PMC_15371550","title":"SMAR1 and Cux/CDP modulate chromatin and act as negative regulators of the TCRbeta enhancer (Ebeta).","date":"2004","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/15371550","citation_count":36,"is_preprint":false},{"pmid":"16972798","id":"PMC_16972798","title":"A novel proteolytically processed CDP/Cux isoform of 90 kDa is generated by cathepsin L.","date":"2006","source":"Biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16972798","citation_count":36,"is_preprint":false},{"pmid":"24940603","id":"PMC_24940603","title":"New Clox Systems for rapid and efficient gene disruption in Candida albicans.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24940603","citation_count":35,"is_preprint":false},{"pmid":"29228286","id":"PMC_29228286","title":"Cut-and-Paste Transposons in Fungi with Diverse Lifestyles.","date":"2017","source":"Genome biology and evolution","url":"https://pubmed.ncbi.nlm.nih.gov/29228286","citation_count":35,"is_preprint":false},{"pmid":"32388635","id":"PMC_32388635","title":"Cathepsin L promotes angiogenesis by regulating the CDP/Cux/VEGF-D pathway in human gastric cancer.","date":"2020","source":"Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association","url":"https://pubmed.ncbi.nlm.nih.gov/32388635","citation_count":34,"is_preprint":false},{"pmid":"11058104","id":"PMC_11058104","title":"The yeast CDP1 gene encodes a triple-helical DNA-binding protein.","date":"2000","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/11058104","citation_count":33,"is_preprint":false},{"pmid":"33000435","id":"PMC_33000435","title":"Circ-CUX1 Accelerates the Progression of Neuroblastoma via miR-16-5p/DMRT2 Axis.","date":"2020","source":"Neurochemical research","url":"https://pubmed.ncbi.nlm.nih.gov/33000435","citation_count":33,"is_preprint":false},{"pmid":"12115525","id":"PMC_12115525","title":"Expression of N-terminally truncated isoforms of CDP/CUX is increased in human uterine leiomyomas.","date":"2002","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/12115525","citation_count":33,"is_preprint":false},{"pmid":"17079132","id":"PMC_17079132","title":"Cut and move: protein machinery for DNA processing in bacterial conjugation.","date":"2006","source":"Current opinion in structural biology","url":"https://pubmed.ncbi.nlm.nih.gov/17079132","citation_count":32,"is_preprint":false},{"pmid":"14756787","id":"PMC_14756787","title":"A CDP-choline pathway for phosphatidylcholine biosynthesis in Treponema denticola.","date":"2004","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/14756787","citation_count":32,"is_preprint":false},{"pmid":"9370323","id":"PMC_9370323","title":"CDP-ethanolamine:1,2-diacylglycerol ethanolaminephosphotransferase.","date":"1997","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/9370323","citation_count":31,"is_preprint":false},{"pmid":"36687696","id":"PMC_36687696","title":"Phosphatidylethanolamine homeostasis under conditions of impaired CDP-ethanolamine pathway or phosphatidylserine decarboxylation.","date":"2023","source":"Frontiers in nutrition","url":"https://pubmed.ncbi.nlm.nih.gov/36687696","citation_count":31,"is_preprint":false},{"pmid":"29331585","id":"PMC_29331585","title":"Cathepsin L promotes ionizing radiation-induced U251 glioma cell migration and invasion through regulating the GSK-3β/CUX1 pathway.","date":"2018","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/29331585","citation_count":31,"is_preprint":false},{"pmid":"32547943","id":"PMC_32547943","title":"CUX1, A Controversial Player in Tumor Development.","date":"2020","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/32547943","citation_count":30,"is_preprint":false},{"pmid":"34921772","id":"PMC_34921772","title":"Making the cut with protease engineering.","date":"2021","source":"Cell chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/34921772","citation_count":30,"is_preprint":false},{"pmid":"15499562","id":"PMC_15499562","title":"Coexpression of Cux-1 and Notch signaling pathway components during kidney development.","date":"2004","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/15499562","citation_count":30,"is_preprint":false},{"pmid":"38105608","id":"PMC_38105608","title":"Cut&tag: a powerful epigenetic tool for chromatin profiling.","date":"2023","source":"Epigenetics","url":"https://pubmed.ncbi.nlm.nih.gov/38105608","citation_count":28,"is_preprint":false},{"pmid":"29518378","id":"PMC_29518378","title":"The crux of Cux genes in neuronal function and plasticity.","date":"2018","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/29518378","citation_count":28,"is_preprint":false},{"pmid":"9130595","id":"PMC_9130595","title":"Cux/CDP homeodomain protein binds to an enhancer in the rat c-mos locus and represses its activity.","date":"1997","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/9130595","citation_count":28,"is_preprint":false},{"pmid":"19332113","id":"PMC_19332113","title":"The homeodomain protein Cux1 interacts with Grg4 to repress p27 kip1 expression during kidney development.","date":"2009","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/19332113","citation_count":28,"is_preprint":false},{"pmid":"33931647","id":"PMC_33931647","title":"Cut-like homeobox 1 (CUX1) tumor suppressor gene haploinsufficiency induces apoptosis evasion to sustain myeloid leukemia.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/33931647","citation_count":27,"is_preprint":false},{"pmid":"36725417","id":"PMC_36725417","title":"Gene editing for dyslipidemias: New tools to \"cut\" lipids.","date":"2023","source":"Atherosclerosis","url":"https://pubmed.ncbi.nlm.nih.gov/36725417","citation_count":26,"is_preprint":false},{"pmid":"28147323","id":"PMC_28147323","title":"The DNA repair function of CUX1 contributes to radioresistance.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/28147323","citation_count":25,"is_preprint":false},{"pmid":"29671584","id":"PMC_29671584","title":"Tailored Polyproteins Using Sequential Staple and Cut.","date":"2018","source":"Bioconjugate chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29671584","citation_count":25,"is_preprint":false},{"pmid":"18356167","id":"PMC_18356167","title":"Polycystic kidneys caused by sustained expression of Cux1 isoform p75.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18356167","citation_count":25,"is_preprint":false},{"pmid":"29036362","id":"PMC_29036362","title":"CUX1 stimulates APE1 enzymatic activity and increases the resistance of glioblastoma cells to the mono-alkylating agent temozolomide.","date":"2018","source":"Neuro-oncology","url":"https://pubmed.ncbi.nlm.nih.gov/29036362","citation_count":24,"is_preprint":false},{"pmid":"8978028","id":"PMC_8978028","title":"CDP1, a novel Saccharomyces cerevisiae gene required for proper nuclear division and chromosome segregation.","date":"1996","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8978028","citation_count":23,"is_preprint":false},{"pmid":"34647658","id":"PMC_34647658","title":"Identification of chromatin states during zebrafish gastrulation using CUT&RUN and CUT&Tag.","date":"2021","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/34647658","citation_count":23,"is_preprint":false},{"pmid":"34473231","id":"PMC_34473231","title":"Loss of a 7q gene, CUX1, disrupts epigenetically driven DNA repair and drives therapy-related myeloid neoplasms.","date":"2021","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/34473231","citation_count":22,"is_preprint":false},{"pmid":"37117763","id":"PMC_37117763","title":"Post-GWAS functional analysis identifies CUX1 as a regulator of p16INK4a and cellular senescence.","date":"2022","source":"Nature aging","url":"https://pubmed.ncbi.nlm.nih.gov/37117763","citation_count":22,"is_preprint":false},{"pmid":"19895633","id":"PMC_19895633","title":"Moyamoya: to cut or not to cut is not the only question. A paediatric neurologist's perspective.","date":"2009","source":"Developmental medicine and child neurology","url":"https://pubmed.ncbi.nlm.nih.gov/19895633","citation_count":21,"is_preprint":false},{"pmid":"35416745","id":"PMC_35416745","title":"Chemical inhibition of polyphenol oxidase and cut surface browning of fresh-cut apples.","date":"2022","source":"Critical reviews in food science and nutrition","url":"https://pubmed.ncbi.nlm.nih.gov/35416745","citation_count":20,"is_preprint":false},{"pmid":"15673290","id":"PMC_15673290","title":"Differential expression of Cux-1 and p21 in polycystic kidneys from Pkd1 null and cpk mice.","date":"2005","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/15673290","citation_count":18,"is_preprint":false},{"pmid":"37644171","id":"PMC_37644171","title":"CUX1-related neurodevelopmental disorder: deep insights into phenotype-genotype spectrum and underlying pathology.","date":"2023","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/37644171","citation_count":17,"is_preprint":false},{"pmid":"35084368","id":"PMC_35084368","title":"The significance of CUX1 and chromosome 7 in myeloid malignancies.","date":"2022","source":"Current opinion in hematology","url":"https://pubmed.ncbi.nlm.nih.gov/35084368","citation_count":17,"is_preprint":false},{"pmid":"40274823","id":"PMC_40274823","title":"DHODH modulates immune evasion of cancer cells via CDP-Choline dependent regulation of phospholipid metabolism and ferroptosis.","date":"2025","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/40274823","citation_count":17,"is_preprint":false},{"pmid":"35422047","id":"PMC_35422047","title":"CDP-ribitol prodrug treatment ameliorates ISPD-deficient muscular dystrophy mouse model.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/35422047","citation_count":17,"is_preprint":false},{"pmid":"20224295","id":"PMC_20224295","title":"The roles of CUX1 homeodomain proteins in the establishment of a transcriptional program required for cell migration and invasion.","date":"2010","source":"Cell adhesion & migration","url":"https://pubmed.ncbi.nlm.nih.gov/20224295","citation_count":17,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":46488,"output_tokens":8144,"usd":0.130812,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":17689,"output_tokens":5918,"usd":0.118197,"stage2_stop_reason":"end_turn"},"total_usd":0.249009,"stage1_batch_id":"msgbatch_01ACAxJQabDsht39JXeWG22d","stage2_batch_id":"msgbatch_01QEU22A9U5sbPTgsMzTmvSf","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2004,\n      \"finding\": \"Cathepsin L, via isoforms devoid of a signal peptide that localize to the nucleus during G1-S transition, proteolytically processes CDP/Cux (CUX1) to generate the p110 isoform, thereby regulating cell cycle progression.\",\n      \"method\": \"Ectopic expression of cathepsin L, Cat L(-/-) knockout cells, immunofluorescence imaging, activity-based probes for nuclear cathepsin L localization, in situ processing assay\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (KO cells, ectopic expression, activity-based probes, immunofluorescence), replicated in both gain- and loss-of-function contexts\",\n      \"pmids\": [\"15099520\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"CDP/Cux (CUX1) DNA binding activity is up-regulated at G1/S transition by two events: dephosphorylation by Cdc25A phosphatase and proteolytic processing to generate the p110 isoform with stable DNA binding.\",\n      \"method\": \"Cell cycle synchronization, Western blot, EMSA, in vitro DNA binding assays\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — biochemical characterization from multiple lines of investigation consolidated in a review but referencing primary cell-based assays; single lab summary\",\n      \"pmids\": [\"11403998\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Cyclin A-Cdk1 binds CDP/Cux (CUX1) via the Cut homeodomain and a downstream Cy motif, and phosphorylates serines 1237 and 1270, thereby inhibiting CDP/Cux DNA binding activity in G2 and preventing repression of the p21(WAF1) promoter.\",\n      \"method\": \"In vitro kinase/binding assays, site-directed mutagenesis (S1237A/S1270A), co-immunoprecipitation, cotransfection reporter assays, cell synchronization\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro phosphorylation with mutagenesis validation, co-IP, and reporter assays in one study; single lab with multiple orthogonal methods\",\n      \"pmids\": [\"11584018\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"N-terminally truncated CDP/Cux isoforms (p110) act as transcriptional activators of the DNA polymerase alpha gene promoter in S phase, whereas full-length CDP/Cux does not; ChIP confirmed S-phase-specific promoter occupancy.\",\n      \"method\": \"Cotransfection reporter assays, retroviral expression, chromatin immunoprecipitation (ChIP), linker scanning analysis, in vitro DNA binding\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus reporter assays plus endogenous gene activation; multiple orthogonal methods, single lab\",\n      \"pmids\": [\"12665598\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"The CDP/Cux p75 isoform, generated by transcription initiation within intron 20, contains only Cut repeat 3 and the homeodomain, binds DNA stably, represses the p21 promoter, and activates the DNA polymerase alpha promoter; aberrant expression in breast tumor cells promotes undifferentiated growth.\",\n      \"method\": \"Northern/Western blot characterization, reporter assays (repression/activation), stable cell line experiments (collagen tubulogenesis assay)\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — biochemical isoform characterization plus functional cell-based assays; single lab, multiple methods\",\n      \"pmids\": [\"12438259\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"A 90 kDa CDP/Cux isoform (p90) is generated by cathepsin L-mediated proteolytic processing, with its N-terminus between amino acids 918 and 938; p90 and p110 display similar DNA-binding and transcriptional activities.\",\n      \"method\": \"Deletion mutant mapping, co-expression with catalytically active cathepsin L isoforms lacking signal peptide, Western blot\",\n      \"journal\": \"Biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — biochemical mapping with deletion mutants and cathepsin L co-expression; single lab, two complementary approaches\",\n      \"pmids\": [\"16972798\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"CUX1 (p110 isoform) and E2F1 co-occupy the promoters of Ect2, MgcRacGAP, and MKLP1 upon S-phase entry and cooperatively activate their transcription; CHR elements mediate G1 repression, and CUX1/E2F1 binding drives peak G2/M expression to coordinate cytokinesis.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP), promoter-luciferase reporter assays, dominant-negative and activated transcription factor expression, siRNA knockdown, Western blot\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus reporter assays plus loss-of-function siRNA, multiple orthogonal methods in one study\",\n      \"pmids\": [\"19015243\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"CUX1 functions as an ancillary factor in base excision repair by directly stimulating OGG1 enzymatic activity via its CUT domains, accelerating repair of 8-oxoG lesions; elevated CUX1 prevents RAS-induced senescence by reducing oxidative DNA damage.\",\n      \"method\": \"In vitro base excision repair assays with purified CUX1 and OGG1, single-cell gel electrophoresis (comet assay) in Cux1+/- MEFs and elevated-CUX1 cells, RAS-induced senescence assay, transgenic mouse model\",\n      \"journal\": \"PLoS biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution with purified proteins, haploinsufficiency comet assay, and mouse model; multiple orthogonal methods across genetic and biochemical approaches\",\n      \"pmids\": [\"24618719\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"CUX1 CUT domains stimulate APE1 (apurinic/apyrimidinic endonuclease 1) enzymatic activity in vitro; CUX1 knockdown decreases APE1 activity in cell extracts and increases abasic sites, while CUX1 overexpression has the opposite effect, promoting resistance to temozolomide.\",\n      \"method\": \"In vitro DNA repair assay with purified CUT domains and APE1, cell extract APE1 activity assay, abasic site quantification, CUX1 knockdown/overexpression in glioblastoma cells, clonogenic survival\",\n      \"journal\": \"Neuro-oncology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with purified proteins plus cell-based gain/loss-of-function; single lab with multiple orthogonal methods\",\n      \"pmids\": [\"29036362\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"A recombinant protein containing only two CUT domains of CUX1 is sufficient for rapid recruitment to DNA damage sites, acceleration of base excision repair, and increased cell survival following ionizing radiation.\",\n      \"method\": \"CUT domain truncation experiments, DNA damage recruitment assay, clonogenic survival assay, OGG1 inhibitor treatment\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — domain truncation plus functional survival assay; single lab, two orthogonal approaches\",\n      \"pmids\": [\"28147323\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"CUX1 recruits the histone methyltransferase EHMT2 to DNA double-strand breaks, promoting downstream H3K9 and H3K27 methylation, phosphorylated ATM retention, γH2AX focus formation and propagation, and 53BP1 recruitment, thereby mediating epigenetically driven DNA repair in hematopoietic stem and progenitor cells.\",\n      \"method\": \"CUX1-deficient mouse HSPCs, mechanistic epistasis analysis, γH2AX foci, 53BP1 recruitment assays, ChIP for histone marks at DNA breaks\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mechanistic dissection in primary HSPCs with multiple chromatin readouts; single lab\",\n      \"pmids\": [\"34473231\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"CUX1 (p110 isoform) modulates constitutive expression of ATM, ATR, and DNA damage response genes; CUX1 knockdown reduces ATM/ATR expression and impairs ATM autophosphorylation, Chk2/p53 phosphorylation, γH2AX and Rad51 foci, and DNA strand break repair after IR and UV.\",\n      \"method\": \"Genome-wide ChIP-chip (promoter arrays), RNAi knockdown, genetic inactivation, Western blot for phosphorylation markers, DNA damage foci immunofluorescence, clonogenic survival, cell cycle checkpoint analysis\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genome-wide promoter binding plus RNAi and genetic KO with multiple damage-response readouts; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"22319212\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"CUX1 directly transcriptionally represses PIK3IP1 (a PI3K inhibitor); CUX1 deficiency leads to increased PI3K-AKT signaling and enhanced tumor growth, validating CUX1 as a tumor suppressor via the PI3K pathway.\",\n      \"method\": \"Transcriptional reporter assays, ChIP, Drosophila cancer models, mouse transposon insertional mutagenesis, PI3K/AKT inhibitor treatment of CUX1-mutant tumors\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct ChIP evidence for PIK3IP1 repression, cross-validated in multiple model organisms, with pharmacological rescue; replicated across systems\",\n      \"pmids\": [\"24316979\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"CUX1 knockdown in human CD34+ cells decreases expression of PIK3IP1 (PI3K inhibitor) and elevates PI3K/AKT signaling, promoting HSC exit from quiescence and proliferation leading to HSC exhaustion; restoration of CUX1 expression reverses MDS disease in mice.\",\n      \"method\": \"shRNA mouse models with graded CUX1 knockdown, bone marrow transplantation, RNA-sequencing, functional HSC quiescence assays, PI3K signaling pathway analysis\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — graded shRNA mouse models with disease rescue, RNA-seq, and functional HSC assays; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"29592892\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"CUX1 directly represses the CFLAR (FLIP) promoter; CUX1 haploinsufficiency de-represses CFLAR, driving apoptosis evasion in AML cells. Genome-wide CRISPR/Cas9 screening identified CFLAR as a selective vulnerability in CUX1-deficient AML.\",\n      \"method\": \"Genome-wide CRISPR/Cas9 loss-of-function screen, CFLAR promoter ChIP and reporter assays, CUX1 knockdown/KO in murine and human AML cells, IAP antagonist treatment\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — CRISPR screen plus ChIP plus promoter reporter plus functional apoptosis assays; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"33931647\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"CUX1 binds to an atherosclerosis-associated SNP (rs1537371) in the CDKN2A/B locus and regulates expression of p14ARF, p15INK4b, p16INK4a, and ANRIL in endothelial cells; CUX1 induction triggers p16INK4a-dependent replicative and stress-induced senescence.\",\n      \"method\": \"Electrophoretic mobility shift assay (EMSA) for SNP binding, reporter assays, CUX1 knockdown/overexpression, senescence assays (β-galactosidase, p16 expression)\",\n      \"journal\": \"Nature aging\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — direct DNA binding to SNP with EMSA plus functional senescence assays; single lab, two orthogonal approaches\",\n      \"pmids\": [\"37117763\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"CUX1 interacts with NF-κB p65 and recruits HDAC1 to chemokine promoters (e.g., CXCL10), reducing NF-κB p65 acetylation at K310 and repressing NF-κB-regulated cytokines in tumor-associated macrophages, thereby modulating M1 polarization.\",\n      \"method\": \"Co-immunoprecipitation, DNA pulldown, chromatin immunoprecipitation (ChIP), NF-κB reporter assay, CUX1 overexpression/knockdown in macrophages\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — Co-IP plus ChIP plus reporter assay plus functional cytokine profiling; single lab, multiple methods\",\n      \"pmids\": [\"24336331\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"CUX1 and NF-κB p65 co-mediate transcription of CXCL1, CXCL2, and CXCL3 from a unique CUX1-NF-κB binding motif in their promoters in synovial fibroblasts responding to TNF + IL-17A; CUX1 knockdown selectively abolishes this synergistic cytokine response.\",\n      \"method\": \"Gene-silencing transcriptomics, siRNA knockdown, promoter binding motif analysis, transcription factor independence assays (LIFR, STAT3, STAT4, ELF3 ruled out)\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — transcriptomics plus targeted siRNA knockdown and promoter motif analysis; single lab, moderate mechanistic depth\",\n      \"pmids\": [\"32079724\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"CUX1 (p110 and p75 isoforms) stimulates cell migration and invasion; siRNA knockdown of CUX1 reduces motility. CUX1 activates Snail and Slug transcription factors and cooperates with them to repress E-cadherin and occludin, disrupting cell-cell junctions. ChIP-chip identified >20 direct CUX1 target genes involved in cytoskeleton remodeling and Rho GTPase regulation.\",\n      \"method\": \"siRNA knockdown migration/invasion assays, ectopic expression experiments, ChIP-chip (promoter arrays), reporter assays for Snail/Slug/E-cadherin/occludin\",\n      \"journal\": \"Cell adhesion & migration\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — ChIP-chip plus migration/invasion assays plus reporter assays; single lab, multiple methods\",\n      \"pmids\": [\"20224295\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"CUX1 in neurons transcriptionally represses p27(Kip1) expression to regulate dendritic complexity; this effect requires the DNA-binding domains of CUX1 and is mediated downstream via RhoA.\",\n      \"method\": \"CUX1 overexpression and knockdown in cortical neurons, quantitative morphological analysis of dendrites, reporter assays, dominant-negative and activated RhoA epistasis experiments\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — loss- and gain-of-function in neurons with pathway epistasis; single lab, partial mechanistic follow-up\",\n      \"pmids\": [\"20485671\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Cux1 and Cux2 regulate dendrite branching, spine development, and synapse formation in layer II-III cortical neurons partly through direct transcriptional regulation of chromatin remodeling genes Xlr3b and Xlr4b; knockout mice show reduced synaptic function and working memory deficits.\",\n      \"method\": \"Cux1/Cux2 knockout mice, shRNA knockdown, morphological analysis, electrophysiology, behavioral testing, gene expression analysis\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — KO mice plus knockdown with morphological, electrophysiological, and behavioral readouts, replicated across two genes\",\n      \"pmids\": [\"20510857\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"CDP/Cux C-terminus deletion (including the homeodomain) abolishes nuclear localization of the mutant protein and eliminates HiNF-D DNA binding activity in nuclear extracts; specific histone genes H4.1 and H1 containing CDP/Cux binding sites show reduced expression in homozygous mutant MEFs.\",\n      \"method\": \"Genetically targeted mouse (ΔC allele), indirect immunofluorescence, EMSA with nuclear extracts, Northern blot for histone genes\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo genetic model with direct localization and DNA binding assays; single lab, multiple readouts\",\n      \"pmids\": [\"11839809\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Cux/CDP is the identity component of NF-muNR and represses the immunoglobulin heavy chain intronic enhancer (Emu) by antagonizing the Bright transcription activator at matrix attachment regions (MARs), both at the DNA binding and functional levels.\",\n      \"method\": \"Expression library screening, EMSA supershift with Cux/CDP antiserum, cotransfection reporter assays, affinity-purified NF-muNR Western blot\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — EMSA supershift plus reporter assays plus biochemical identification; single lab, multiple methods\",\n      \"pmids\": [\"9858552\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Cux1 directly binds the p27(kip1) promoter in vivo and interacts with co-repressor Grg4 to enhance repression; ChIP assays show co-occupancy of Cux1, Grg4, HDAC1, and HDAC3 at two sites in the p27(kip1) promoter in newborn kidney tissue.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP) in kidney tissue, co-immunoprecipitation for Cux1-Grg4 interaction, promoter reporter (luciferase) assays, DNase I footprinting\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo ChIP in tissue plus Co-IP plus reporter plus footprinting; single lab, four orthogonal methods\",\n      \"pmids\": [\"19332113\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Sustained expression of p75-Cux1 isoform in transgenic mice causes polycystic kidneys; chromatin affinity purification confirmed direct binding of Cux1 to c-myc and p27 promoters, with upregulation of c-myc and downregulation of p27, increased cilia length, and elevated epithelial proliferation.\",\n      \"method\": \"Transgenic mouse model, chromatin affinity purification (ChAP), Western blot, immunohistochemistry, proliferation index\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — transgenic model plus ChAP for direct promoter occupancy; single lab, two methods\",\n      \"pmids\": [\"18356167\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"SMAR1 and Cux/CDP physically interact with each other, co-localize in the perinuclear region, and independently repress the TCRbeta enhancer (Emu) via MARbeta; SMAR1 repressor activity is strongly enhanced in the presence of Cux/CDP. Overexpression of both proteins modulates chromatin structure at MARbeta as shown by DNase I hypersensitivity.\",\n      \"method\": \"Co-immunoprecipitation for SMAR1-Cux/CDP interaction, immunofluorescence colocalization, reporter gene cotransfection assays, DNase I hypersensitivity\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — Co-IP plus reporter assays plus chromatin structure analysis; single lab, multiple methods\",\n      \"pmids\": [\"15371550\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"CDP/Cut (CUX1) binds to a silencer element in the lactoferrin promoter (identified as a ~180 kDa protein by UV cross-linking/EMSA) in non-LF-expressing hematopoietic cells; CDP/cut overexpression blocks lactoferrin expression upon granulocyte colony-stimulating factor-induced neutrophil maturation.\",\n      \"method\": \"Luciferase reporter transfections, EMSA, UV cross-linking, Western blot identification, overexpression in myeloid stem cells\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — EMSA plus UV cross-linking identification plus functional reporter and overexpression assays; single lab\",\n      \"pmids\": [\"9326246\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Cathepsin L proteolytically processes CDP/Cux (CUX1) to produce the p110 isoform in gastric cancer; p110 then stably binds the VEGF-D promoter and activates VEGF-D transcription, promoting tumor angiogenesis.\",\n      \"method\": \"Western blot for p110 generation, co-immunoprecipitation of CTSL and CUX1, dual-luciferase reporter assay for VEGF-D promoter, endothelial tube formation/HUVEC migration, CAM assay\",\n      \"journal\": \"Gastric cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — biochemical processing assay plus reporter plus functional angiogenesis assays; single lab, multiple methods\",\n      \"pmids\": [\"32388635\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Ionizing radiation reduces GSK-3β activity via CTSL-mediated phosphorylation of Ser9; CTSL also processes CUX1 to the p110 isoform, which then promotes EMT and increases glioma cell migration and invasion.\",\n      \"method\": \"Western blot for GSK-3β phosphorylation, CTSL overexpression/knockdown, CUX1 processing assay, migration/invasion assays\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — Western blot-based mechanistic claims; single lab, single-method per step\",\n      \"pmids\": [\"29331585\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"CUX1 and GLIS1 cooperate to stimulate TCF/β-catenin transcriptional activity and enhance cell migration and invasion; co-expression experiments in breast cancer model demonstrate their joint activation of Wnt pathway target genes.\",\n      \"method\": \"TCF/β-catenin reporter assay, co-expression experiments, Wnt inhibitor (FZD/LRP receptor inhibitors), laser-capture microdissection gene expression profiling\",\n      \"journal\": \"Biology open\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — reporter assay and co-expression with pharmacological inhibition; single lab, limited mechanistic resolution\",\n      \"pmids\": [\"25217618\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"Clox (mammalian CUX1/CDP) proteins are nuclear DNA-binding proteins with sequence specificity similar to Drosophila Cut; cotransfection experiments demonstrate they function as repressors of tissue-specific gene transcription.\",\n      \"method\": \"cDNA cloning, Western blot, EMSA, cotransfection transcription repression assays\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — EMSA plus cotransfection reporter assays; foundational characterization with two orthogonal methods\",\n      \"pmids\": [\"1363085\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"CUX1 in SVZ precursor cells shows nuclear localization in BrdU-positive dividing SVZ cells but weak diffuse localization in VZ cells, suggesting CUX1 function is first activated in SVZ intermediate progenitors.\",\n      \"method\": \"Immunofluorescence with anti-Cux-1 antibody, BrdU labeling, Pax-6 null mutation analysis\",\n      \"journal\": \"The Journal of comparative neurology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — immunofluorescence localization study without direct functional consequence experiment for this specific finding\",\n      \"pmids\": [\"15452856\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Cux-1 is significantly upregulated downstream of constitutively active Notch 1 signaling in rat kidney epithelial cells, and Cux1 interacts with the Groucho homolog TLE-4 co-repressor (which is recruited by Notch effector proteins), linking CUX1 to the Notch pathway.\",\n      \"method\": \"Constitutively active Notch 1 overexpression in RKE cells, Western blot, co-immunoprecipitation of Cux1 with TLE-4\",\n      \"journal\": \"Developmental dynamics\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single Co-IP and overexpression experiment; single lab, limited mechanistic depth\",\n      \"pmids\": [\"15499562\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Cux/CDP binds to the c-mos upstream enhancer site III via Cut repeat CR3 and the homeodomain (both required for efficient binding) and represses c-mos enhancer activity in cotransfection assays.\",\n      \"method\": \"GST-fusion protein pull-down with deletion mutants, EMSA supershift with anti-hCut antibodies, CAT reporter cotransfection assays\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — domain mapping with deletion mutants plus EMSA supershift plus reporter assay; single lab, three methods\",\n      \"pmids\": [\"9130595\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CUX1 encodes multiple isoforms (p200/full-length, p110, p90, p75) generated by proteolytic processing via nuclear cathepsin L and/or alternative transcription initiation; the p110 isoform, whose DNA binding is activated at G1/S by Cdc25A dephosphorylation and then inhibited in G2 by cyclin A-Cdk1 phosphorylation at S1237/S1270, acts as a cell-cycle-dependent transcriptional activator (e.g., DNA pol-α, Ect2/MgcRacGAP/MKLP1) and repressor (p21, p27, PIK3IP1, CFLAR, CXCL1-3) through its CUT domains and homeodomain; additionally, the CUT domains function as ancillary factors that directly stimulate OGG1 and APE1 enzymatic activities to accelerate base excision repair and, together with recruited EHMT2-driven histone methylation, orchestrate the DNA damage response, while CUX1 also interacts with NF-κB p65 (recruiting HDAC1) and co-repressors Grg4/TLE-4 to modulate inflammation and development, and haploinsufficiency of CUX1 de-represses PIK3IP1 and CFLAR, activating PI3K-AKT signaling and promoting apoptosis evasion in myeloid neoplasms.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"CUX1 (CDP/Cut) is a homeodomain transcription factor that uses CUT-repeat and homeodomain DNA-binding modules to control gene programs governing cell-cycle progression, the DNA damage response, and tissue development, and that functions as a haploinsufficient tumor suppressor [#3, #7, #12]. Multiple functional isoforms are produced from the full-length p200 protein: nuclear cathepsin L proteolytically processes CUX1 during the G1/S transition to generate the stably DNA-binding p110 (and p90) isoform [#0, #5], while a shorter p75 isoform arises from transcription initiation within intron 20 [#4]. The DNA-binding activity of p110 is cell-cycle gated — activated at G1/S by Cdc25A dephosphorylation and processing [#1], then inhibited in G2 by cyclin A-Cdk1 phosphorylation at S1237/S1270 [#2]. Functionally, CUX1 acts as both an activator and a repressor: it activates the DNA polymerase alpha promoter in S phase [#3], cooperates with E2F1 to drive G2/M expression of the cytokinesis genes Ect2, MgcRacGAP, and MKLP1 [#6], and represses cell-cycle inhibitors including p21 [#2] and p27(Kip1), the latter via recruitment of the co-repressor Grg4 with HDAC1/HDAC3 [#23, #19]. Independent of transcription, the CUT domains act as ancillary base-excision-repair factors that directly stimulate OGG1 and APE1 enzymatic activity and are rapidly recruited to damage sites to accelerate repair [#7, #8, #9], while CUX1 also transcriptionally sustains ATM/ATR expression and recruits the histone methyltransferase EHMT2 to double-strand breaks to drive H3K9/H3K27 methylation and 53BP1 recruitment [#11, #10]. As a tumor suppressor, CUX1 directly represses the PI3K inhibitor PIK3IP1 and the apoptosis regulator CFLAR, such that CUX1 haploinsufficiency de-represses these targets, activating PI3K-AKT signaling and promoting apoptosis evasion in myeloid neoplasms [#12, #13, #14]. CUX1 additionally partners with NF-\\u03baB p65 to modulate chemokine transcription in inflammation [#16, #17] and, with Cux2, regulates dendritic and synaptic development in cortical neurons [#20].\",\n  \"teleology\": [\n    {\n      \"year\": 1992,\n      \"claim\": \"Established the founding biochemical identity of mammalian CUX1 as a sequence-specific nuclear DNA-binding protein related to Drosophila Cut that represses tissue-specific transcription.\",\n      \"evidence\": \"cDNA cloning, EMSA, and cotransfection repression assays\",\n      \"pmids\": [\"1363085\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No isoform structure or cell-cycle regulation defined\", \"Direct target genes not yet mapped\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Defined how CUX1 contacts DNA and represses targets, showing CUT repeat CR3 plus the homeodomain are both required for binding, and linked CUX1 to repression of myeloid maturation genes.\",\n      \"evidence\": \"GST pulldown domain mapping, EMSA supershift, and reporter assays on c-mos and lactoferrin promoters\",\n      \"pmids\": [\"9130595\", \"9326246\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Did not address isoform-specific binding\", \"No genome-wide target identification\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Resolved how CUX1 DNA binding is gated across the cell cycle, showing G1/S activation by Cdc25A dephosphorylation and processing, and G2 inhibition by cyclin A-Cdk1 phosphorylation at S1237/S1270 that relieves p21 repression.\",\n      \"evidence\": \"Cell synchronization, EMSA, in vitro kinase/binding assays, S1237A/S1270A mutagenesis, and reporter assays\",\n      \"pmids\": [\"11403998\", \"11584018\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the processing protease not established here\", \"Did not address activator function\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Demonstrated isoform diversification by identifying the p75 isoform from intronic transcription initiation and confirming CUX1 DNA binding and nuclear localization require the C-terminal homeodomain in vivo.\",\n      \"evidence\": \"Isoform characterization, reporter assays, transgenic/targeted mouse models, and EMSA\",\n      \"pmids\": [\"12438259\", \"11839809\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism generating p110 still unresolved\", \"Physiological relevance of histone gene targets unclear\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Revealed that processed N-terminally truncated CUX1 acts as a transcriptional activator, not just repressor, occupying the DNA polymerase alpha promoter specifically in S phase.\",\n      \"evidence\": \"ChIP, reporter assays, retroviral expression, and linker scanning\",\n      \"pmids\": [\"12665598\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Determinants of activator vs repressor switching not defined\", \"Cofactors for activation unknown\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Identified nuclear cathepsin L as the protease that generates the p110 isoform during G1/S, providing the mechanistic basis for cell-cycle-coupled CUX1 activation.\",\n      \"evidence\": \"Cathepsin L knockout cells, ectopic expression, activity-based probes, and in situ processing assays\",\n      \"pmids\": [\"15099520\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cleavage site not precisely mapped here\", \"Regulation of nuclear cathepsin L entry incompletely defined\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Connected CUX1 to developmental signaling and chromatin-anchoring repression, linking it to Notch via TLE-4 and to matrix-attachment-region repression via SMAR1.\",\n      \"evidence\": \"Co-IP, immunofluorescence colocalization, and reporter assays in kidney and lymphoid models\",\n      \"pmids\": [\"15499562\", \"15371550\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"TLE-4 link rests on a single Co-IP and overexpression\", \"Functional consequences of SMAR1 interaction in vivo unclear\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Mapped the cathepsin L-generated p90 isoform N-terminus and showed it shares DNA-binding and transcriptional activity with p110, refining the processing model.\",\n      \"evidence\": \"Deletion-mutant mapping and co-expression with active cathepsin L isoforms\",\n      \"pmids\": [\"16972798\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Distinct in vivo roles of p90 vs p110 not separated\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Extended CUX1 activator function into mitosis, showing cooperation with E2F1 to drive G2/M expression of cytokinesis genes Ect2, MgcRacGAP, and MKLP1.\",\n      \"evidence\": \"ChIP, promoter-luciferase assays, siRNA knockdown, and dominant-negative expression\",\n      \"pmids\": [\"19015243\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct physical CUX1-E2F1 complex not structurally defined\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Established a co-repressor mechanism for p27(Kip1) repression in vivo, showing Cux1 recruits Grg4 with HDAC1/HDAC3 to the promoter in kidney tissue.\",\n      \"evidence\": \"In vivo ChIP, Co-IP, reporter assays, and DNase I footprinting\",\n      \"pmids\": [\"19332113\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Generality across tissues not addressed\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Defined developmental and pro-invasive roles, showing Cux1/Cux2 control dendrite and synapse formation via Xlr3b/Xlr4b, that CUX1 represses p27 to regulate dendrite complexity through RhoA, and that CUX1 promotes EMT/invasion via Snail/Slug.\",\n      \"evidence\": \"Knockout mice, electrophysiology, behavior, neuronal gain/loss-of-function, ChIP-chip, and invasion assays\",\n      \"pmids\": [\"20510857\", \"20485671\", \"20224295\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Isoform contributions to neuronal phenotypes not separated\", \"Pro-invasive role context dependence unclear\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Showed CUX1 broadly sustains the DNA damage response by transcriptionally maintaining ATM/ATR expression, with knockdown impairing checkpoint signaling and repair.\",\n      \"evidence\": \"Genome-wide ChIP-chip, RNAi, genetic inactivation, damage foci imaging, and clonogenic survival\",\n      \"pmids\": [\"22319212\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not yet distinguish transcriptional from direct repair roles\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Defined CUX1 as a haploinsufficient tumor suppressor acting through PI3K, showing direct repression of PIK3IP1 such that CUX1 loss activates PI3K-AKT and enhances tumor growth, and revealing NF-\\u03baB-coupled inflammatory repression.\",\n      \"evidence\": \"ChIP, reporter assays, Drosophila and mouse transposon models, pharmacological PI3K inhibition, and macrophage Co-IP/ChIP\",\n      \"pmids\": [\"24316979\", \"24336331\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full set of haploinsufficiency-relevant targets incomplete\", \"NF-\\u03baB mechanism is Medium-confidence single lab\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Established a non-transcriptional repair function, showing CUX1 CUT domains directly stimulate OGG1 to accelerate 8-oxoG base excision repair and prevent RAS-induced senescence.\",\n      \"evidence\": \"In vitro repair reconstitution with purified proteins, comet assays in Cux1+/- MEFs, and a transgenic mouse model\",\n      \"pmids\": [\"24618719\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of CUT domain-OGG1 stimulation undefined\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Generalized the ancillary-repair mechanism to APE1, showing CUT domains stimulate APE1 activity and that CUX1 levels set abasic-site burden and chemoresistance in glioblastoma.\",\n      \"evidence\": \"In vitro repair assays with purified CUT domains and APE1, cell extract activity assays, and clonogenic survival with temozolomide\",\n      \"pmids\": [\"29036362\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether CUT domains act on additional BER enzymes unknown\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Showed a minimal two-CUT-domain fragment is sufficient for rapid recruitment to damage sites and radioprotection, isolating the repair function from full-length CUX1.\",\n      \"evidence\": \"CUT domain truncation, damage recruitment assays, OGG1 inhibition, and clonogenic survival\",\n      \"pmids\": [\"28147323\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Recruitment mechanism to lesions not defined\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Linked radiation signaling to CUX1 processing, proposing CTSL-mediated p110 generation drives glioma EMT and invasion.\",\n      \"evidence\": \"Western blot of GSK-3\\u03b2 phosphorylation, CTSL gain/loss-of-function, processing assay, and invasion assays\",\n      \"pmids\": [\"29331585\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Mechanistic claims rest largely on single-method Western blots\", \"Causal chain from GSK-3\\u03b2 to CUX1 to EMT not established\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Extended CUX1-NF-\\u03baB cooperation to a defined promoter motif, showing CUX1 is required for synergistic CXCL1-3 induction by TNF + IL-17A in synovial fibroblasts, and showed cathepsin L-generated p110 activates VEGF-D to promote angiogenesis.\",\n      \"evidence\": \"Silencing transcriptomics, siRNA, motif analysis, processing assays, and angiogenesis assays\",\n      \"pmids\": [\"32079724\", \"32388635\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct CUX1-p65 complex composition at chemokine promoters incompletely defined\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Connected the repair and tumor-suppressor roles in hematopoiesis, showing CUX1 recruits EHMT2 to double-strand breaks for epigenetic repair and represses CFLAR, with haploinsufficiency creating apoptosis evasion and a targetable CFLAR vulnerability in AML.\",\n      \"evidence\": \"CUX1-deficient mouse HSPCs, ChIP for histone marks, gamma-H2AX/53BP1 assays, genome-wide CRISPR screen, CFLAR ChIP/reporter, and IAP antagonist treatment\",\n      \"pmids\": [\"34473231\", \"33931647\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Order of EHMT2 recruitment relative to other repair factors not fully resolved\", \"CFLAR study single lab\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Implicated CUX1 in vascular aging, showing it binds an atherosclerosis-associated SNP in the CDKN2A/B locus and triggers p16INK4a-dependent endothelial senescence.\",\n      \"evidence\": \"EMSA for SNP binding, reporter assays, gain/loss-of-function, and senescence assays\",\n      \"pmids\": [\"37117763\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Genotype-specific effect on disease risk not directly tested in vivo\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the same CUT/homeodomain modules are partitioned between transcription and direct enzymatic stimulation of repair enzymes, and what dictates isoform- and context-specific activator-vs-repressor outputs, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural model of CUT domain engagement with OGG1/APE1 or DNA\", \"Determinants switching CUX1 between activation and repression undefined\", \"Mechanism of recruitment to DNA damage sites not established\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [3, 21, 30, 33, 15]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [3, 6, 12, 14, 23, 30]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [7, 8, 9]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 21, 30, 31]},\n      {\"term_id\": \"GO:0005654\", \"supporting_discovery_ids\": [10, 11, 23]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [2, 3, 6]},\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [7, 8, 9, 10, 11]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [3, 12, 14, 23, 30]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [12, 13]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [15, 7]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"CTSL\", \"E2F1\", \"RELA\", \"EHMT2\", \"OGG1\", \"APE1\", \"TLE4\", \"HDAC1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}